RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn FDA Peptide Reclassification 2026: What It Means for Providers FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law